PCVXCongressional Stock Trades
Vaxcyte, Inc. Common Stock
Biological Products, (No Diagnostic Substances)
Congressional stock trades in Vaxcyte, Inc. Common Stock (PCVX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
5
Politicians Trading
2
Last Traded
Jul 16, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Sep 4, 2026 | Jul 16, 2026 | Buy | $1,001 - $15,000 | +3.73% |
| Gilbert Ray Cisneros, Jr.D | May 6, 2025 | Apr 28, 2025 | Buy | $1,001 - $15,000 | +76.69% |
| Gilbert Ray Cisneros, Jr.D | May 6, 2025 | Apr 15, 2025 | Buy | $1,001 - $15,000 | +92.29% |
| Gilbert Ray Cisneros, Jr.D | May 6, 2025 | Apr 14, 2025 | Buy | $1,001 - $15,000 | +81.43% |
| Jefferson ShreveR | Apr 11, 2025 | Mar 5, 2025 | Sell | $15,001 - $50,000 | -21.33% |
Price History
About Vaxcyte, Inc. Common Stock
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.